Insulin-like growth factor-1 stimulates retinal cell proliferation via activation of multiple signaling pathways.

Cell proliferation Central nervous system Epidermal growth factor Insulin-like growth factor-1 Retina Signaling pathway

Journal

Current research in neurobiology
ISSN: 2665-945X
Titre abrégé: Curr Res Neurobiol
Pays: Netherlands
ID NLM: 101778135

Informations de publication

Date de publication:
2023
Historique:
received: 17 07 2022
revised: 05 09 2022
accepted: 12 12 2022
entrez: 2 1 2023
pubmed: 3 1 2023
medline: 3 1 2023
Statut: epublish

Résumé

Insulin-like growth factor-1 (IGF-1) plays critical roles in the development of the central nervous system (CNS), including the retina, regulating cell proliferation, differentiation, and survival. Here, we investigated the role of IGF-1 on retinal cell proliferation using primary cultures from rat neural retina. Our data show that IGF-1 stimulates retinal cell proliferation and regulates the expression of neurotrophic factors, such as interleukin-4 and brain-derived neurotrophic factor. In addition, our results indicates that IGF-1-induced retinal cell proliferation requires activation of multiple signaling pathways, including phosphatidylinositol 3-kinase, protein kinase Src, phospholipase-C, protein kinase C delta, and mitogen-activated protein kinase pathways. We further show that activation of matrix metalloproteinases and epidermal growth factor receptor is also necessary for IGF-1 enhancing retinal cell proliferation. Overall, these results unveil potential mechanisms by which IGF-1 ensures retinal cell proliferation and support the notion that manipulation of IGF-1 signaling may be beneficial in CNS disorders associated with abnormal cell proliferation.

Identifiants

pubmed: 36589675
doi: 10.1016/j.crneur.2022.100068
pii: S2665-945X(22)00041-9
pmc: PMC9800307
doi:

Types de publication

Journal Article

Langues

eng

Pagination

100068

Informations de copyright

© 2022 The Authors.

Déclaration de conflit d'intérêts

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Références

Neurochem Res. 2022 Mar;47(3):723-738
pubmed: 34783975
Neurochem Res. 2021 Jul;46(7):1701-1716
pubmed: 33792824
J Invest Dermatol. 2016 Jan;136(1):e1-e7
pubmed: 26763463
FEBS Lett. 2006 Oct 2;580(22):5161-6
pubmed: 16970944
Front Neuroendocrinol. 2012 Aug;33(3):230-51
pubmed: 22710100
Cell Mol Neurobiol. 2015 Mar;35(2):243-54
pubmed: 25274047
Mol Vis. 2013 Sep 12;19:1901-12
pubmed: 24049436
Cancer Res. 2008 Dec 1;68(23):9712-22
pubmed: 19047149
Nat Med. 1999 Dec;5(12):1390-5
pubmed: 10581081
Invest Ophthalmol Vis Sci. 2014 Apr 29;55(6):3385-94
pubmed: 24781942
Oncotarget. 2015 Mar 10;6(7):4829-44
pubmed: 25638159
PLoS One. 2013;8(1):e54462
pubmed: 23349896
Cancer Res. 2021 Jan 15;81(2):414-425
pubmed: 33318039
J Diabetes Complications. 2006 May-Jun;20(3):196-204
pubmed: 16632241
Mol Neurobiol. 2017 Nov;54(9):6931-6943
pubmed: 27774572
Development. 2021 Apr 1;148(7):
pubmed: 33722901
Biochem Biophys Res Commun. 2018 Jun 12;500(4):917-923
pubmed: 29705702
Anticancer Res. 2005 May-Jun;25(3B):2039-41
pubmed: 16158942
J Biol Chem. 2000 Jul 21;275(29):22583-9
pubmed: 10807918
J Biol Chem. 2007 Apr 13;282(15):11329-38
pubmed: 17303558
PLoS One. 2016 Dec 8;11(12):e0167778
pubmed: 27930693
J Clin Invest. 2004 Apr;113(8):1149-57
pubmed: 15085194
Neurochem Int. 2003 Jan;42(1):73-80
pubmed: 12441170
Development. 2006 Jun;133(11):2201-10
pubmed: 16672338
J Biol Chem. 2004 Jan 16;279(3):1713-9
pubmed: 14593113
Stem Cells. 2015 Aug;33(8):2416-30
pubmed: 25827910
Biochem Biophys Res Commun. 2019 Oct 29;519(1):53-60
pubmed: 31474338
J Biol Chem. 1998 Feb 20;273(8):4672-80
pubmed: 9468528
Mol Cell Biol. 1998 Oct;18(10):5888-98
pubmed: 9742106
Invest Ophthalmol Vis Sci. 2015 Oct;56(11):6948-60
pubmed: 26513500
Invest Ophthalmol Vis Sci. 2007 Sep;48(9):4315-20
pubmed: 17724222
Neurosci Lett. 2013 Aug 29;550:29-34
pubmed: 23827230
Stem Cells. 2021 Apr;39(4):458-466
pubmed: 33442906
Mol Neurobiol. 2018 Feb;55(2):1123-1135
pubmed: 28097474
Neurochem Res. 2010 Sep;35(9):1343-52
pubmed: 20499167
Brain Res Dev Brain Res. 2005 Jan 1;154(1):91-100
pubmed: 15617759
PLoS One. 2017 Sep 25;12(9):e0185164
pubmed: 28945762
Cell Signal. 2006 Sep;18(9):1461-72
pubmed: 16403461
Neurochem Int. 2007 Apr;50(5):741-8
pubmed: 17363111
Cell Res. 2002 Mar;12(1):9-18
pubmed: 11942415
Free Radic Biol Med. 2007 Jun 1;42(11):1651-60
pubmed: 17462533
Cell Cycle. 2018;17(4):515-526
pubmed: 29417866
Neurochem Res. 2008 May;33(5):754-64
pubmed: 17940890
Mol Cell Biol. 2001 May;21(9):2981-90
pubmed: 11287604
Mech Dev. 2002 Sep;117(1-2):137-49
pubmed: 12204254
Nat Rev Neurosci. 2012 Mar 20;13(4):225-39
pubmed: 22430016

Auteurs

Camila Saggioro de Figueiredo (CS)

Department of Neurobiology and Program of Neurosciences, Institute of Biology, Fluminense Federal University, Niterói, 24210-200, Brazil.

Ícaro Raony (Í)

Institute of Medical Biochemistry Leopoldo de Meis, Federal University of Rio de Janeiro, Rio de Janeiro, 21941-902, Brazil.

Simone Vidal Medina (SV)

Department of Neurobiology and Program of Neurosciences, Institute of Biology, Fluminense Federal University, Niterói, 24210-200, Brazil.

Eliezer de Mello Silva (E)

Department of Neurobiology and Program of Neurosciences, Institute of Biology, Fluminense Federal University, Niterói, 24210-200, Brazil.

Aline Araujo Dos Santos (AA)

Department of Physiology and Pharmacology and Program of Neurosciences, Fluminense Federal University, Niterói, 24210-130, Brazil.

Elizabeth Giestal-de-Araujo (E)

Department of Neurobiology and Program of Neurosciences, Institute of Biology, Fluminense Federal University, Niterói, 24210-200, Brazil.
National Institute of Science and Technology on Neuroimmunomodulation - INCT-NIM, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, 21040-360, Brazil.

Classifications MeSH